These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19584729)

  • 1. Pathogenesis of kidney disease in systemic lupus erythematosus.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2009 Sep; 21(5):489-94. PubMed ID: 19584729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2005 Sep; 17(5):523-8. PubMed ID: 16093828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes.
    Bagavant H; Deshmukh US; Wang H; Ly T; Fu SM
    J Immunol; 2006 Dec; 177(11):8258-65. PubMed ID: 17114504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.
    Bagavant H; Deshmukh US; Gaskin F; Fu SM
    Scand J Immunol; 2004; 60(1-2):52-63. PubMed ID: 15238073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA; Trouw LA; Daha MR
    Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of tissue injury in lupus nephritis.
    Nowling TK; Gilkeson GS
    Arthritis Res Ther; 2011; 13(6):250. PubMed ID: 22192660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
    Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
    J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model.
    Zhu Y; Yue Y; Xiong S
    Clin Exp Immunol; 2018 Sep; 193(3):302-312. PubMed ID: 29704464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.
    Xia W; Eltrich N; Vielhauer V
    Front Immunol; 2024; 15():1377913. PubMed ID: 38799420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into disease pathogenesis from mouse lupus genetics.
    Jørgensen TN; Gubbels MR; Kotzin BL
    Curr Opin Immunol; 2004 Dec; 16(6):787-93. PubMed ID: 15511674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
    Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner.
    Celhar T; Lu HK; Benso L; Rakhilina L; Lee HY; Tripathi S; Zharkova O; Ong WY; Yasuga H; Au B; Marlier D; Lim LHK; Thamboo TP; Mudgett JS; Mackey MF; Zaller DM; Connolly JE; Fairhurst AM
    Front Immunol; 2019; 10():1546. PubMed ID: 31354711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Lupus Nephritis: Clinical Implications.
    Munroe ME; James JA
    Semin Nephrol; 2015 Sep; 35(5):396-409. PubMed ID: 26573543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of lupus nephritis.
    Lech M; Anders HJ
    J Am Soc Nephrol; 2013 Sep; 24(9):1357-66. PubMed ID: 23929771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the role of renal resident cells in the pathogenesis of lupus nephritis.
    Kwok SK; Tsokos GC
    Korean J Intern Med; 2018 Mar; 33(2):284-289. PubMed ID: 29320847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis.
    Kikuchi S; Fossati-Jimack L; Moll T; Amano H; Amano E; Ida A; Ibnou-Zekri N; Laporte C; Santiago-Raber ML; Rozzo SJ; Kotzin BL; Izui S
    J Immunol; 2005 Jan; 174(2):1111-7. PubMed ID: 15634937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.
    Mohan C; Putterman C
    Nat Rev Nephrol; 2015 Jun; 11(6):329-41. PubMed ID: 25825084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the immunopathogenesis of systemic lupus erythematosus.
    Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
    Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.